328 related articles for article (PubMed ID: 28420489)
1. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
[TBL] [Abstract][Full Text] [Related]
2. Link between mast cells and bacteria: Antimicrobial defense, function and regulation by cytokines.
Conti P; Carinci F; Caraffa A; Ronconi G; Lessiani G; Theoharides TC
Med Hypotheses; 2017 Sep; 106():10-14. PubMed ID: 28818263
[TBL] [Abstract][Full Text] [Related]
3. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
[TBL] [Abstract][Full Text] [Related]
4. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37.
Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S
Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657
[TBL] [Abstract][Full Text] [Related]
5. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
6. Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers.
Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa Al; Conti P
J Biol Regul Homeost Agents; 2016; 30(4):945-950. PubMed ID: 28078840
[TBL] [Abstract][Full Text] [Related]
7. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
[TBL] [Abstract][Full Text] [Related]
8. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.
Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G
Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470
[TBL] [Abstract][Full Text] [Related]
9. Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37.
Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
Eur J Pharmacol; 2018 Jan; 818():294-299. PubMed ID: 28970014
[TBL] [Abstract][Full Text] [Related]
10. Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37.
Trimarchi M; Lauritano D; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Calvisi V; Conti P
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362030
[TBL] [Abstract][Full Text] [Related]
11. Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37.
Mastrangelo F; Frydas I; Ronconi G; Kritas SK; Tettamanti L; Caraffa Al; D Ovidio C; Younes A; Gallenga CE; Conti P
J Biol Regul Homeost Agents; 2018; 32(2):195-198. PubMed ID: 29684996
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
13. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 family cytokines and mast cells: activation and inhibition.
Gallenga CE; Pandolfi F; Caraffa Al; Kritas SK; Ronconi G; Toniato E; Martinotti S; Conti P
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):1-6. PubMed ID: 30656901
[TBL] [Abstract][Full Text] [Related]
15. Impact of mold on mast cell-cytokine immune response.
Kritas SK; Gallenga CE; D Ovidio C; Ronconi G; Caraffa Al; Toniato E; Lauritano D; Conti P
J Biol Regul Homeost Agents; 2018; 32(4):763-768. PubMed ID: 30043558
[TBL] [Abstract][Full Text] [Related]
16. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.
Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC
Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882
[TBL] [Abstract][Full Text] [Related]
17. Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues.
Conti P; Caraffa Al; Kritas SK; Ronconi G; Lessiani G; Toniato E; Theoharides TC
J Biol Regul Homeost Agents; 2017; 31(2):263-267. PubMed ID: 28685525
[TBL] [Abstract][Full Text] [Related]
18. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
[TBL] [Abstract][Full Text] [Related]
19. Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Frydas I; Theoharides TC
Inflamm Res; 2018 Sep; 67(9):747-755. PubMed ID: 29961151
[TBL] [Abstract][Full Text] [Related]
20. New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators.
Caraffa Al; Conti C; D Ovidio C; Gallenga CE; Tettamanti L; Mastrangelo F; Ronconi G; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2018; 32(3):449-454. PubMed ID: 29921369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
